Apollo Hospitals Enterprise Ltd. (APOLLOHOSP): Apollo Hospitals Share Price Hits Fresh 52-Week High
- July 30, 2026
- Posted by: Harsh Piplani
- Category: News
Apollo Hospitals Share Price hits a fresh 52-week high at Rs 9,009, up 0.6% today, with a market cap of Rs 1,28,055.33 Cr.
Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) has reached a fresh 52-week high, with its share price touching Rs 9,009 today. The stock opened at Rs 8,931.55 and closed previously at Rs 8,931.65, marking a 0.6% increase with a current price of Rs 8,984.85. The market capitalisation stands at Rs 1,28,055.33 crore, reflecting significant investor interest in the healthcare sector. This milestone highlights the stock’s strong performance in the market, driven by factors that may include sector dynamics and peer performance.
Apollo Hospitals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 8,984.85 |
| Previous Close | Rs 8,931.65 |
| Today's Change | +Rs 53.2 (+0.6%) |
| Day Open | Rs 8,931.55 |
| Fresh 52-Week High | Rs 9,009 |
| Day Low | Rs 8,862.3 |
| Current Volume | 2,930 |
| Turnover | Rs 2.63 crore |
| Market Capitalisation | Rs 1,28,055.33 crore |
Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) traded at Rs 8,984.85. versus the previous close of Rs 8,931.65, a rise of 0.6%. The stock opened at Rs 8,931.55, reached Rs 9,009, touched Rs 8,862.3. Reported volume was 2,930.
Today, Apollo Hospitals’ share price reached a fresh 52-week high of Rs 9,009, with a day change of Rs 53.2, representing a 0.6% increase. The stock opened at Rs 8,931.55 and fluctuated between a low of Rs 8,862.3 and a high of Rs 9,009. The turnover for the day was Rs 2.63 crore, with a volume of 2,930 shares traded. This price action indicates robust market activity and investor confidence in the company’s prospects.
Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,28,055.33 crore |
| P/E Ratio | 30.28x |
| P/B Ratio | 0.44x |
| ROE | -2.89% |
| ROCE | -0.26% |
Apollo Hospitals Enterprise Ltd. was valued at a P/E ratio of 30.28x, a P/B ratio of 0.44x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 30.28x |
| Benchmark Median P/E | 21.7x |
| Benchmark Average P/E | 68.16x |
| Benchmark P/E Range | 0x to 3,385.56x |
| Company P/B Ratio | 0.44x |
| Benchmark Median P/B | 1.9x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.73% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.2% |
| Company Market Capitalisation | Rs 1,28,055.33 crore |
| Benchmark Median Market Cap | Rs 138.42 crore |
Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) is classified under sector: Healthcare.
Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) has a P/E ratio of 30.28x, which is above the benchmark median of 21.7x, a difference of +39.54%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) has a ROE of -2.89%, which is below the benchmark median of 10.73%, a difference of -126.93%. Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) has a ROCE of -0.26%, which is below the benchmark median of 13.2%, a difference of -101.97%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,856.59 | 30.28 | 0.44 | -2.89 | -0.26 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,686.76 | 40.11 | 8.17 | 28.21 | 26.35 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,432.22 | 34.7 | 7.02 | -2.6 | 16.92 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,415.06 | 171.06 | 3.16 | 13.9 | 12.97 |
| Beta Drugs Ltd. | BETA | 2,338.9 | 59.68 | 9.44 | 18.65 | 22.17 |
Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) has a P/E ratio of 30.28x compared with the displayed peer median of 40.11x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) has a market capitalisation of Rs 1,28,055.33 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Apollo Hospitals
- Fresh 52-week high at Rs 9,009, indicating strong price momentum.
- Competitive P/E ratio within the healthcare sector.
- Significant market capitalisation compared to peers.
- Potential undervaluation suggested by low P/B ratio.
- Dominant position in the healthcare sector.
About Apollo Hospitals
Apollo Hospitals Enterprise Ltd. is a leading healthcare provider in India, offering a wide range of medical services and facilities. The company operates hospitals, clinics, and pharmacies, serving millions of patients annually. With a strong presence in the healthcare sector, Apollo Hospitals is known for its advanced medical technology and comprehensive healthcare solutions. The company’s focus on quality care and innovation has established it as a trusted name in the industry.
Track Apollo Hospitals Share Price on Univest
Use Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors can track Apollo Hospitals Share Price, technical indicators, fundamental ratios, shareholding pattern, 52-week levels, and market insights on Univest for comprehensive market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of Apollo Hospitals?
Ans. The current share price of Apollo Hospitals is Rs 8,984.85, reflecting a 0.6% increase from the previous close. The stock moved 0.6% during the session. The intraday range extended from Rs 8,862.3 to Rs 9,009.
What is the market capitalisation of Apollo Hospitals?
Ans. Apollo Hospitals has a market capitalisation of Rs 1,28,055.33 crore, indicating its significant size in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 30.28x.
How does Apollo Hospitals' P/E ratio compare to the sector?
Ans. Apollo Hospitals' P/E ratio of 30.28 is above the sector median of 21.7, suggesting a moderate valuation within the healthcare sector. The company trades at a P/E ratio of 30.28x.
What is Apollo Hospitals' 52-week high?
Ans. Apollo Hospitals' 52-week high is Rs 9,009, achieved today, indicating strong price momentum. The stock moved 0.6% during the session. The intraday range extended from Rs 8,862.3 to Rs 9,009.
How does Apollo Hospitals' P/B ratio compare to the sector?
Ans. Apollo Hospitals' P/B ratio of 0.44 is significantly below the sector median of 1.9, suggesting potential undervaluation. The company trades at a P/E ratio of 30.28x. Its P/B ratio is 0.44x.
What is Apollo Hospitals' ROE?
Ans. Apollo Hospitals' ROE is -2.89%, indicating challenges in generating returns on equity. ROE stands at -2.89%. ROCE stands at -0.26%. The relevant peer median ROE is 10.73%. The relevant peer median ROCE is 13.2%.
How does Apollo Hospitals' market cap compare to its peers?
Ans. Apollo Hospitals' market cap of Rs 1,28,055.33 crore is substantially higher than peers like Dishman Carbogen, highlighting its dominant market position. The company operates in the Healthcare sector. Its P/E ratio is 30.28x.
What is Apollo Hospitals' ROCE?
Ans. Apollo Hospitals' ROCE is -0.26%, reflecting challenges in efficiently using capital employed. ROE stands at -2.89%. ROCE stands at -0.26%. The relevant peer median ROE is 10.73%. The relevant peer median ROCE is 13.2%.
